• Prelude Therapeutics' (PRLD) "Buy" Rating Reaffirmed at HC Wainwright

    Source: Buzz FX / 08 Nov 2024 13:16:17   America/New_York


    Prelude Therapeutics' (PRLD) "Buy" Rating Reaffirmed at HC Wainwright Written by MarketBeat November 8, 2024 Share Link copied to clipboard. Prelude Therapeutics ( NASDAQ:PRLD - Get Free Report ) 's stock had its "buy" rating reissued by re
    Read more...
Share on,